The increased expression of ANGPTL4 observed in tumor cells at the invasive front in the overweight/obese group now provides novel in vivo evidence supporting a role for ANGPTL4 in obesity-related breast cancer. The gene discussed is ANGPTL4; the disease is obesity due to melanocortin 4 receptor deficiency.